Literature DB >> 9496369

Maternal viral load, CD4 cell count and vertical transmission of HIV-1.

S O'Shea1, M L Newell, D T Dunn, M C Garcia-Rodriguez, I Bates, J Mullen, T Rostron, K Corbett, S Aiyer, K Butler, R Smith, J E Banatvala.   

Abstract

HIV load and CD4 cell numbers were measured among 95 HIV infected women during pregnancy in order to determine their value as prognostic markers for transmission of virus from mother to infant. Among the 94 live births, 13 children were infected with HIV, 69 were uninfected and 12 were of unknown infection status. HIV RNA levels, as measured by nucleic acid sequence based amplification, were significantly higher (P < 0.001) in women who transmitted virus than among those who did not transmit and maternal viral load was a stronger predictor of transmission than CD4 cell number. The predicted rate of transmission relative to maternal HIV RNA was 2% at 1,000 copies, 11% at 10,000 copies and 40% at 100,000 copies/ml. Little variation in viral load occurred during pregnancy and there was an association between viral load and prematurity, the mean gestation at delivery decreasing by 1.3 weeks for every 10-fold increase in maternal HIV RNA (P = 0.007). This study demonstrates that a high level of maternal HIV RNA is a risk factor for transmission of virus to the infant and maternal viral load is of more value as a prognostic marker for transmission risk than CD4 cell number. High viral load is also associated with premature delivery. Maternal viral load is therefore a useful marker on which to base management decisions during pregnancy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9496369     DOI: 10.1002/(sici)1096-9071(199802)54:2<113::aid-jmv8>3.0.co;2-9

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  9 in total

Review 1.  British HIV Association guidelines for prescribing antiretroviral therapy in pregnancy (1998).

Authors:  G P Taylor; E G Lyall; D Mercey; R Smith; T Chester; M L Newell; G Tudor-Williams
Journal:  Sex Transm Infect       Date:  1999-04       Impact factor: 3.519

2.  Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model.

Authors:  Justin G Julander; Venkatraman Siddharthan; Joe Evans; Ray Taylor; Kelsey Tolbert; Chad Apuli; Jason Stewart; Preston Collins; Makda Gebre; Skot Neilson; Arnaud Van Wettere; Young-Min Lee; William P Sheridan; John D Morrey; Y S Babu
Journal:  Antiviral Res       Date:  2016-11-10       Impact factor: 5.970

3.  Association of selected phenotypic markers of lymphocyte activation and differentiation with perinatal human immunodeficiency virus transmission and infant infection.

Authors:  John S Lambert; Jack Moye; Susan F Plaeger; E Richard Stiehm; James Bethel; Lynne M Mofenson; Bonnie Mathieson; Jonathan Kagan; Howard Rosenblatt; Helene Paxton; Hildie Suter; Alan Landay
Journal:  Clin Diagn Lab Immunol       Date:  2005-05

4.  Antenatal HIV-1 RNA load and timing of mother to child transmission; a nested case-control study in a resource poor setting.

Authors:  Kerina Duri; Felicity Z Gumbo; Knut I Kristiansen; Nyaradzi E Kurewa; Munyaradzi P Mapingure; Simbarashe Rusakaniko; Mike Z Chirenje; Fredrik Muller; Babill Stray-Pedersen
Journal:  Virol J       Date:  2010-08-02       Impact factor: 4.099

Review 5.  Four decades of leading-edge research in the reproductive and developmental sciences: the Infant Primate Research Laboratory at the University of Washington National Primate Research Center.

Authors:  Thomas M Burbacher; Kimberly S Grant; Julie Worlein; James Ha; Eliza Curnow; Sandra Juul; Gene P Sackett
Journal:  Am J Primatol       Date:  2013-07-19       Impact factor: 2.371

6.  Maternal plasma viral load and neutralizing/enhancing antibodies in vertical transmission of HIV: a non-randomized prospective study.

Authors:  Paul Kamara; Loyda Melendez-Guerrero; Miguel Arroyo; Heidi Weiss; Pauline Jolly
Journal:  Virol J       Date:  2005-02-24       Impact factor: 4.099

7.  Increasing adolescent HIV prevalence in Eastern Zimbabwe--evidence of long-term survivors of mother-to-child transmission?

Authors:  Jeffrey W Eaton; Geoffrey P Garnett; Felicia R Takavarasha; Peter R Mason; Laura Robertson; Christina M Schumacher; Constance A Nyamukapa; Simon Gregson
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240

Review 8.  Understanding Viral and Immune Interplay During Vertical Transmission of HIV: Implications for Cure.

Authors:  Omayma Amin; Jenna Powers; Katherine M Bricker; Ann Chahroudi
Journal:  Front Immunol       Date:  2021-10-21       Impact factor: 7.561

9.  Mother-to-Child HIV Transmission With In Utero Dolutegravir vs. Efavirenz in Botswana.

Authors:  Sonya Davey; Gbolahan Ajibola; Kenneth Maswabi; Maureen Sakoi; Kara Bennett; Michael D Hughes; Arielle Isaacson; Modiegi Diseko; Rebecca Zash; Oganne Batlang; Sikhulile Moyo; Shahin Lockman; Mathias Lichterfeld; Daniel R Kuritzkes; Joseph Makhema; Roger Shapiro
Journal:  J Acquir Immune Defic Syndr       Date:  2020-07-01       Impact factor: 3.771

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.